| Product NDC: | 0009-0233 |
| Proprietary Name: | Bacitracin |
| Non Proprietary Name: | Bacitracin |
| Active Ingredient(s): | 50000 [iU]/1 & nbsp; Bacitracin |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-0233 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA060733 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19480729 |
| Package NDC: | 0009-0233-03 |
| Package Description: | 10 VIAL in 1 CARTON (0009-0233-03) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| NDC Code | 0009-0233-03 |
| Proprietary Name | Bacitracin |
| Package Description | 10 VIAL in 1 CARTON (0009-0233-03) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 0009-0233 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bacitracin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19480729 |
| Marketing Category Name | ANDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | BACITRACIN |
| Strength Number | 50000 |
| Strength Unit | [iU]/1 |
| Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE] |